Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts

Reprod Sci. 2016 Jan;23(1):112-23. doi: 10.1177/1933719115597787. Epub 2015 Aug 4.

Abstract

Progesterone (P(4)) maintains uterine quiescence during the majority of pregnancy, whereas diminished progesterone receptor (PR) expression and/or activity (ie, functional P(4) withdrawal) promotes parturition. To investigate the regulation of PR expression in cervical stroma, fibroblasts from premenopausal hysterectomy specimens were prepared. Greater than 99% of the cultures were vimentin positive (mesenchymal cell marker) with only occasional cytokeratin-8 positivity (epithelial cell marker) and no evidence of CD31-positive (endothelial cell marker) cells. Cells were immunolabeled with antibodies directed against PRs (PR-A and PR-B), estrogen receptor α (ER-α), and glucocorticoid receptor-α/β (GR-α/β). All cells were uniformly immunopositive for ER-α and GR-α/β but did not express PRs. Incubation of cells with 10(-8) mol/L 17β-estradiol induced a time-dependent increase in PR-A and PR-B messenger RNAs (mRNAs) by quantitative real-time polymerase chain reactions and proteins by immunoblotting and immunofluorescence. Incubation of cervical fibroblasts with PR ligands (medroxyprogesterone acetate or Org-2058) downregulated PR-A and PR-B levels. Coincubation of cells with PR ligands plus RU-486, a PR antagonist, partially abrogated agonist-induced receptor downregulation. Dexamethasone, a pure glucocorticoid, had no inhibitory effect on PR expression. These results indicate that progestins and estrogens regulate PR expression in cervical fibroblasts. We postulate that hormonal regulation of PR expression in the cervical stroma may contribute to functional P(4) withdrawal in preparation for parturition.

Keywords: cervix; estradiol; parturition; progesterone receptor; receptor downregulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cervix Uteri / cytology
  • Cervix Uteri / drug effects*
  • Cervix Uteri / metabolism
  • Down-Regulation / drug effects*
  • Estradiol / pharmacology
  • Female
  • Fibroblasts / cytology
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Hormone Antagonists / pharmacology
  • Humans
  • Medroxyprogesterone Acetate / pharmacology
  • Mifepristone / pharmacology
  • Pregnenediones / pharmacology
  • Receptors, Glucocorticoid / metabolism
  • Receptors, Progesterone / metabolism*

Substances

  • Hormone Antagonists
  • Pregnenediones
  • Receptors, Glucocorticoid
  • Receptors, Progesterone
  • glucocorticoid receptor alpha
  • glucocorticoid receptor beta
  • 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
  • Mifepristone
  • Estradiol
  • Medroxyprogesterone Acetate